Medpace Holdings, Inc.
US ˙ NasdaqGS ˙ US58506Q1094

SecurityMEDP / Medpace Holdings, Inc.
InstitutionAxa S.a.
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Axa S.a. closes position in MEDP / Medpace Holdings, Inc.

On November 14, 2025 - Axa S.a. filed a 13F-HR form disclosing ownership of 0 shares of Medpace Holdings, Inc. (US:MEDP) valued at $0 USD as of September 30, 2025. The entity filed a previous 13F-HR on August 14, 2025 disclosing 9,282 shares of Medpace Holdings, Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-11-14 2025-09-30 13F MEDPACE HLDGS COM 58506Q109 0 -9,282 -100.00 0 -100.00
2025-08-14 2025-06-30 13F MEDPACE HLDGS COM 58506Q109 9,282 0 0.00 2,913 3.01 0.0084
2025-05-15 2025-03-31 13F MEDPACE HLDGS COM 58506Q109 9,282 -13,618 -59.47 2,828 -62.83 0.0093
2025-02-14 2024-12-31 13F MEDPACE HLDGS COM 58506Q109 22,900 -9,858 -30.09 7,608 -30.42 0.0231
2024-11-14 2024-09-30 13F MEDPACE HLDGS COM 58506Q109 32,758 -1,260 -3.70 10,935 -21.96 0.0324
2025-02-25 2024-06-30 13F/A-1 MEDPACE HLDGS COM 58506Q109 34,018 3,479 11.39 14,010 13.51 0.0417
2024-08-14 2024-06-30 13F MEDPACE HLDGS COM 58506Q109 34,018 3,479 14,010 0.0417
2024-05-15 2024-03-31 13F MEDPACE HLDGS COM 58506Q109 30,539 -17,052 -35.83 12,342 -15.40 0.0370
2024-07-16 2023-12-31 13F/A-1 MEDPACE HLDGS COM 58506Q109 47,591 11,091 30.39 14,588 65.08 0.0470
2024-02-14 2023-12-31 13F MEDPACE HLDGS COM 58506Q109 47,591 11,091 14,588 0.0286
2023-11-14 2023-09-30 13F MEDPACE HLDGS COM 58506Q109 36,500 -6,100 -14.32 8,838 -13.63 0.0311
2023-08-14 2023-06-30 13F MEDPACE HLDGS COM 58506Q109 42,600 10,700 33.54 10,231 70.57 0.0340
2023-05-15 2023-03-31 13F MEDPACE HLDGS COM 58506Q109 31,900 -8,600 -21.23 5,999 -30.27 0.0206
2023-02-14 2022-12-31 13F MEDPACE HLDGS COM 58506Q109 40,500 -4,100 -9.19 8,603 22.73 0.0310
2023-02-14 2022-09-30 13F/A-1 Medpace Holdings COM 58506Q109 44,600 9,500 27.07 7,010 33.43 0.0276
2022-11-14 2022-09-30 13F Medpace Holdings COM 58506Q109 44,600 9,500 7,010 0.0276
2023-02-14 2022-06-30 13F/A-1 Medpace Holdings COM 58506Q109 35,100 24,800 240.78 5,253 211.94 0.0195
2022-08-15 2022-06-30 13F Medpace Holdings COM 58506Q109 35,100 24,800 5,253 0.0195
2023-02-14 2022-03-31 13F/A-1 Medpace Holdings COM 58506Q109 10,300 -49,900 -82.89 1,685 -87.15 0.0048
2022-05-13 2022-03-31 13F Medpace Holdings COM 58506Q109 10,300 -49,900 1,685 0.0048
2022-02-14 2021-12-31 13F Medpace Holdings COM 58506Q109 60,200 -4,700 -7.24 13,102 6.66 0.0335
2021-11-15 2021-09-30 13F Medpace Holdings COM 58506Q109 64,900 48,200 288.62 12,284 316.41 0.0345
2021-08-13 2021-06-30 13F/A-1 Medpace Holdings COM 58506Q109 16,700 1,800 12.08 2,950 20.70 0.0083
2021-08-13 2021-06-30 13F Medpace Holdings COM 58506Q109 16,700 1,800 2,950 0.0050
2021-05-14 2021-03-31 13F Medpace Holdings COM 58506Q109 14,900 0 0.00 2,444 17.84 0.0074
2021-02-12 2020-12-31 13F Medpace Holdings COM 58506Q109 14,900 2,200 17.32 2,074 46.16 0.0065
2021-02-11 2020-09-30 13F/A-1 Medpace Holdings COM 58506Q109 12,700 0 0.00 1,419 20.15 0.0051
2020-11-13 2020-09-30 13F Medpace Holdings COM 58506Q109 12,700 0 1,419 2,832.5492
2021-02-12 2020-06-30 13F/A-1 MEDPACE HLDGS COM 58506Q109 12,700 -2,600 -16.99 1,181 5.16 0.0047
2020-08-14 2020-06-30 13F MEDPACE HLDGS COM 58506Q109 12,700 -2,600 1,181 4,657.4458
2021-02-12 2020-03-31 13F/A-2 MEDPACE HLDGS COM 58506Q109 15,300 15,300 1,123 0.0056
2020-06-15 2020-03-31 13F/A-1 MEDPACE HLDGS COM 58506Q109 15,300 0 1,123 0.0056
2020-05-15 2020-03-31 13F MEDPACE HLDGS COM 58506Q109 15,300 15,300 1,123 3,123.0823
2019-11-14 2019-09-30 13F MEDPACE HLDGS COM 58506Q109 0 -14,800 -100.00 0 -100.00
2021-02-12 2019-06-30 13F/A-1 MEDPACE HLDGS COM 58506Q109 14,800 -10,900 -42.41 968 -36.15 0.0038
2019-08-13 2019-06-30 13F MEDPACE HLDGS COM 58506Q109 14,800 -10,900 968 3,796.0889
2019-05-14 2019-03-31 13F MEDPACE HLDGS COM 58506Q109 25,700 -29,500 -53.44 1,516 -48.12 0.0059
2019-02-13 2018-12-31 13F MEDPACE HLDGS COM 58506Q109 55,200 28,700 108.30 2,922 84.01 0.0127
2018-11-08 2018-09-30 13F MEDPACE HLDGS COM 58506Q109 26,500 26,500 1,588 0.0058
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.